Stemness Correlates Inversely with MHC Class I Expression in Pediatric Small Round Blue Cell Tumors
Cancers. Bd. 14. H. 15. Basel: MDPI 2022
Erscheinungsjahr: 2022
ISBN/ISSN: 2072-6694
Publikationstyp: Zeitschriftenaufsatz
Sprache: Englisch
Doi/URN: 10.3390/cancers14153584
Inhaltszusammenfassung
Tumors occurring at a young age are distinct from tumors in older individuals, clinically and pathologically. As small round blue cell tumors (SRBCTs), they often show a resemblance to stem cells and immature precursor cells during embryonal development. Recently, immunotherapy has become an option for a subset of patients with limited success. We observed that in almost all the pediatric SRBCT types investigated (n = 1134) there was an inverse relationship, when comparing genes highly expres...Tumors occurring at a young age are distinct from tumors in older individuals, clinically and pathologically. As small round blue cell tumors (SRBCTs), they often show a resemblance to stem cells and immature precursor cells during embryonal development. Recently, immunotherapy has become an option for a subset of patients with limited success. We observed that in almost all the pediatric SRBCT types investigated (n = 1134) there was an inverse relationship, when comparing genes highly expressed in stem cells with genes encoding MHC class I molecules. MHC class I molecules are important in tumor cell recognition by cytotoxic T cells. We suspect that these tumors are derived from multipotent precursor cells that naturally show a low MHC class I expression and a lack of immune recognition necessary for prenatal proliferation and development.» weiterlesen» einklappen
Autoren
Klassifikation
DFG Fachgebiet:
Grundlagen der Biologie und Medizin
DDC Sachgruppe:
Medizin